Bruck Kifle

Array ( [id] => 8834770 [patent_doc_number] => 08450526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Ammoximation process' [patent_app_type] => utility [patent_app_number] => 12/666343 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3892 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340992 [patent_doc_number] => 20100247688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS' [patent_app_type] => utility [patent_app_number] => 12/667445 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21654 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247688.pdf [firstpage_image] =>[orig_patent_app_number] => 12667445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432130 [patent_doc_number] => 07968536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Heterocyclic compounds useful as RAF kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/164905 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57929 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968536.pdf [firstpage_image] =>[orig_patent_app_number] => 12164905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466559 [patent_doc_number] => 20100190786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'INDOLIN-2-ONES AND AZA-INDOLIN-2-ONES' [patent_app_type] => utility [patent_app_number] => 12/663158 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42179 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190786.pdf [firstpage_image] =>[orig_patent_app_number] => 12663158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311224 [patent_doc_number] => 07528249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Cyclic malonamides as inhibitors of aβ protein production' [patent_app_type] => utility [patent_app_number] => 12/142145 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42822 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528249.pdf [firstpage_image] =>[orig_patent_app_number] => 12142145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853184 [patent_doc_number] => 20080318927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Substituted monocyclic CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/214460 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58652 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318927.pdf [firstpage_image] =>[orig_patent_app_number] => 12214460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6249831 [patent_doc_number] => 20100137580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained' [patent_app_type] => utility [patent_app_number] => 12/452152 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 773 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137580.pdf [firstpage_image] =>[orig_patent_app_number] => 12452152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266798 [patent_doc_number] => 20100298293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'SUBSTITUTED OXAZOLIDINONES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/665728 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48042 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298293.pdf [firstpage_image] =>[orig_patent_app_number] => 12665728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954810 [patent_doc_number] => 20110034686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Process for Isolation and Purification of Geldanamycin' [patent_app_type] => utility [patent_app_number] => 12/988802 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3582 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034686.pdf [firstpage_image] =>[orig_patent_app_number] => 12988802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146747 [patent_doc_number] => 08163752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Tricyclic anilide heterocyclic CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/602681 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30742 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163752.pdf [firstpage_image] =>[orig_patent_app_number] => 12602681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619235 [patent_doc_number] => 07998954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Pyrimidodiazepinone derivative' [patent_app_type] => utility [patent_app_number] => 12/602312 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74802 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998954.pdf [firstpage_image] =>[orig_patent_app_number] => 12602312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270528 [patent_doc_number] => 08212026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Process for the preparation of ivabradine hydrochloride and polymorph thereof' [patent_app_type] => utility [patent_app_number] => 12/602348 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6027 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416960 [patent_doc_number] => 20090042847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => '17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN POLYMORPHS AND FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/129369 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23548 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042847.pdf [firstpage_image] =>[orig_patent_app_number] => 12129369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823696 [patent_doc_number] => 20080227982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'SOLVENT FREE AMORPHOUS RAPAMYCIN' [patent_app_type] => utility [patent_app_number] => 12/127467 [patent_app_country] => US [patent_app_date] => 2008-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6827 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227982.pdf [firstpage_image] =>[orig_patent_app_number] => 12127467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779677 [patent_doc_number] => 20080287675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'CASCADE SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/120868 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8669 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287675.pdf [firstpage_image] =>[orig_patent_app_number] => 12120868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527838 [patent_doc_number] => 08304408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Wnt signaling inhibitors, and methods for making and using them' [patent_app_type] => utility [patent_app_number] => 12/600996 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13499 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270521 [patent_doc_number] => 08212025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Process for preparing nevirapine' [patent_app_type] => utility [patent_app_number] => 12/451600 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2462 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374771 [patent_doc_number] => 20100075952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIES,THE PREPARATION AND THE PHARMCETICAL USE THEEOF' [patent_app_type] => utility [patent_app_number] => 12/451466 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54322 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075952.pdf [firstpage_image] =>[orig_patent_app_number] => 12451466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484758 [patent_doc_number] => 07902206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Polymorphic forms α, β and γ of rifaximin' [patent_app_type] => utility [patent_app_number] => 12/119600 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4913 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902206.pdf [firstpage_image] =>[orig_patent_app_number] => 12119600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887900 [patent_doc_number] => 20080262232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'PROCESSES FOR THE PRODUCTION OF POLYMORPHIC FORMS OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 12/119612 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4889 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262232.pdf [firstpage_image] =>[orig_patent_app_number] => 12119612 [rel_patent_id] =>[rel_patent_doc_number] =>)